WebMany commonly prescribed prescription drugs can cause temporary hair loss, trigger the onset of male and female pattern baldness, and even cause permanent hair loss. Note that the drugs listed here do not include those used in chemotherapy and radiation for cancer treatment. Your doctor may not mention hair loss as a side effect of some drugs ... WebExtreme physical stress or shock to your body: This causes temporary hair loss. This category includes events like losing a lot of weight, surgery, anemia, illness and having a baby. Extreme emotional stress: mental …
Cymbalta Side Effects: What They Are and How to Manage Them - Healthline
WebMay 7, 2024 · Hair loss and jaw clenching weren’t reported as side effects in clinical studies of Cymbalta. However, teeth grinding was reported with Cymbalta after the drug’s initial studies were completed. Teeth grinding often occurs in combination with jaw clenching. So, you may also have jaw clenching while taking Cymbalta. WebApr 1, 2024 · numbness, tingling, pain, or weakness in hands or feet. pounding heartbeat. problems in speaking. trembling. trouble sleeping. unpleasant taste or other taste changes. unusual muscle weakness. unusual tiredness. Other side effects not listed may also occur in … california inheritance group
Does Gabapentin Make Your Hair Fall Out? · Bauman Medical
WebApr 24, 2024 · According to the FDA, the risk is greatest in those under the age of 18 and elevated in people ages 18 to 24. This may be because Cymbalta can worse or cause symptoms including anxiety, agitation ... WebDec 14, 2024 · Thankfully, Cymbalta hair loss from telogen effluvium is usually not permanent. Once the cause is identified and addressed, hair tends to return to normal … WebJun 13, 2024 · Lipitor (atovastatin), a cholesterol lowering medication, is associated with hair loss, although it is relatively uncommon. The prescribing information for Lipitor does not list hair loss (sometimes referred to as alopecia in medical literature) as a possible adverse reaction but it has been reported during post-marketing experience with the drug. california informed consent form